Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
MPLN
|
Mark D Klein
Director |
BUY
Open market or private purchase
|
Indirect | 220,000 Added 50.0% |
$2,268,200
$10.31 p/Share
|
Oct 06
2020 |
|
MPLN
|
Michael Stuart Klein
Director |
BUY
Open market or private purchase
|
Indirect | 220,000 Added 50.0% |
$2,268,200
$10.31 p/Share
|
Oct 06
2020 |
|
NSP
|
Arthur A Arizpe
President and COO |
SELL
Open market or private sale
|
Direct | 3,500 Reduced 6.54% |
$246,750
$70.5 p/Share
|
Oct 06
2020 |
|
CRUS
|
Jeffrey W Baumgartner
EVP, R&D |
SELL
Open market or private sale
|
Direct | 19,270 Reduced 66.55% |
$1,348,900
$70.0 p/Share
|
Oct 06
2020 |
|
ESI
|
Martin E Franklin
Director |
BUY
Open market or private purchase
|
Indirect | 500,000 Added 50.0% |
$5,750,000
$11.5 p/Share
|
Oct 06
2020 |
|
LNTH
|
Michael P Duffy
SVP and General Counsel |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 11.24% |
$210,000
$14.0 p/Share
|
Oct 06
2020 |
|
DCI
|
Tod E. Carpenter
Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 11,770 Reduced 6.14% |
$593,914
$50.46 p/Share
|
Oct 06
2020 |
|
DCI
|
Tod E. Carpenter
Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 15,000 Added 7.26% |
$436,050
$29.07 p/Share
|
Oct 06
2020 |
|
DKS
|
Edward W Stack
Executive Chairman |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.01% |
$62,590
$62.59 p/Share
|
Oct 06
2020 |
|
AN
|
Robert R Grusky
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 18.27% |
$600,000
$60.0 p/Share
|
Oct 06
2020 |
|
AN
|
Robert R Grusky
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 15.45% |
$381,800
$38.18 p/Share
|
Oct 06
2020 |
|
MORN
|
Joseph D Mansueto
Executive Chairman |
SELL
Open market or private sale
|
Direct | 652 Reduced 0.0% |
$107,587
$165.01 p/Share
|
Oct 06
2020 |
|
NDSN
|
Mary G Puma
Director |
SELL
Open market or private sale
|
Direct | 1,848 Reduced 9.88% |
$366,126
$198.12 p/Share
|
Oct 06
2020 |
|
PINS
|
Benjamin Silbermann
Director |
SELL
Open market or private sale
|
Direct | 105,000 Reduced 100.0% |
$4,583,250
$43.65 p/Share
|
Oct 06
2020 |
|
PINS
|
Benjamin Silbermann
Director |
BUY
Conversion of derivative security
|
Direct | 105,000 Added 50.0% |
-
|
Oct 06
2020 |
|
SJM
|
Mark T Smucker
CEO, Chair of Board |
BUY
Bona fide gift
|
Indirect | 996 Added 8.53% |
-
|
Oct 06
2020 |
|
SJM
|
Mark T Smucker
CEO, Chair of Board |
SELL
Bona fide gift
|
Indirect | 996 Reduced 100.0% |
-
|
Oct 06
2020 |
|
SPLK
|
Ledger Susan St.
President, WW Field Operations |
SELL
Open market or private sale
|
Direct | 1,624 Reduced 1.04% |
$324,719
$199.95 p/Share
|
Oct 06
2020 |
|
SPLK
|
Graham Smith |
SELL
Open market or private sale
|
Direct | 500 Reduced 1.41% |
$100,000
$200.0 p/Share
|
Oct 06
2020 |
|
SPLK
|
Scott Morgan
SVP, CLO, GLOBAL AFFAIRS & SEC |
SELL
Open market or private sale
|
Direct | 582 Reduced 0.79% |
$116,400
$200.0 p/Share
|
Oct 06
2020 |
|
BBY
|
Richard M Schulze |
SELL
Open market or private sale
|
Indirect | 209,575 Reduced 5.15% |
$24,166,093
$115.31 p/Share
|
Oct 06
2020 |
|
INCY
|
Dashyant Dhanak
EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 961 Reduced 3.32% |
$88,383
$91.97 p/Share
|
Oct 06
2020 |
|
INCY
|
Dashyant Dhanak
EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 961 Added 3.21% |
$62,869
$65.42 p/Share
|
Oct 06
2020 |
|
MDB
|
Dev Ittycheria
President & CEO |
SELL
Open market or private sale
|
Direct | 225,000 Reduced 50.2% |
$54,310,501
$241.38 p/Share
|
Oct 06
2020 |
|
MDB
|
Dev Ittycheria
President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 225,000 Added 33.42% |
$1,462,500
$6.5 p/Share
|
Oct 06
2020 |
|
MDB
|
Michael Lawrence Gordon
COO and CFO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 8.41% |
$2,436,300
$243.63 p/Share
|
Oct 06
2020 |
|
MDB
|
Michael Lawrence Gordon
COO and CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 7.76% |
$65,000
$6.5 p/Share
|
Oct 06
2020 |
|
STE
|
Daniel A Carestio
President and CEO |
SELL
Open market or private sale
|
Direct | 13,500 Reduced 33.91% |
$2,464,965
$182.59 p/Share
|
Oct 06
2020 |
|
STE
|
Daniel A Carestio
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 13,500 Added 25.32% |
$1,040,445
$77.07 p/Share
|
Oct 06
2020 |
|
VEEV
|
Eleni Nitsa Zuppas
President & Chief of Staff |
SELL
Open market or private sale
|
Direct | 4,099 Reduced 35.54% |
$1,176,167
$286.94 p/Share
|
Oct 06
2020 |
|
DELL
|
Thomas W Sweet
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 57.09% |
$6,816,000
$68.16 p/Share
|
Oct 06
2020 |
|
DELL
|
Thomas W Sweet
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 100,000 Added 36.34% |
$1,375,000
$13.75 p/Share
|
Oct 06
2020 |
|
CTAS
|
Michael Lawrence Thompson
Executive Vice President & CAO |
SELL
Open market or private sale
|
Direct | 49,092 Reduced 66.87% |
$16,244,543
$330.9 p/Share
|
Oct 06
2020 |
|
EMR
|
William H Easter Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 733 Added 35.48% |
-
|
Oct 06
2020 |
|
META
|
Jennifer Newstead
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 426 Reduced 16.5% |
$111,612
$262.0 p/Share
|
Oct 06
2020 |
|
HYMC
|
Mudrick Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 3,222,222 Added 11.34% |
-
|
Oct 06
2020 |
|
HYMC
|
Mudrick Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 3,222,222 Added 11.34% |
-
|
Oct 06
2020 |
|
FPRX
|
Bvf Partners L P |
BUY
Open market or private purchase
|
Direct | 345,241 Added 37.88% |
$1,740,015
$5.04 p/Share
|
Oct 06
2020 |
|
ONCR
|
James E Flynn
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,000,000 Added 25.98% |
$15,000,000
$15.0 p/Share
|
Oct 06
2020 |
|
ONCR
|
James E Flynn
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 1,848,970 Added 37.9% |
-
|
Oct 06
2020 |
|
RUN
|
Tiger Global Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 194,345 Reduced 1.13% |
$15,224,987
$78.34 p/Share
|
Oct 06
2020 |
|
RUN
|
Tiger Global Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 9,429 Reduced 0.13% |
$719,810
$76.34 p/Share
|
Oct 06
2020 |
|
RUN
|
Tiger Global Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 75,789 Reduced 0.34% |
$5,988,089
$79.01 p/Share
|
Oct 06
2020 |
|
ONCR
|
Mpm Bio Ventures 2014, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 173,776 Added 5.75% |
$2,606,640
$15.0 p/Share
|
Oct 06
2020 |
|
ONCR
|
Mpm Bio Ventures 2014, L.P.
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 2,559,854 Added 35.45% |
-
|
Oct 06
2020 |
|
ONCR
|
Ubs Oncology Impact Fund L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 151,224 Added 5.98% |
$2,268,360
$15.0 p/Share
|
Oct 06
2020 |
|
ONCR
|
Ubs Oncology Impact Fund L.P.
> 10% Shareholder |
BUY
Conversion of derivative security
|
Direct | 2,225,801 Added 50.0% |
-
|
Oct 06
2020 |
|
SCHW
|
Brian M Levitt
Director |
BUY
Grant, award, or other acquisition
|
Direct | 21,846 Added 50.0% |
-
|
Oct 06
2020 |
|
SCHW
|
Todd M Ricketts
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 303,187 Added 50.0% |
-
|
Oct 06
2020 |
|
SCHW
|
Todd M Ricketts
Director |
BUY
Grant, award, or other acquisition
|
Direct | 203,801 Added 50.0% |
-
|
Oct 06
2020 |